Fibronostics
PrivateLast Round
Series A
Extension
Jun 15, 2022
Total Funding Raised
$14.5M
Company Overview
Fibronostics operates in Healthcare & Life Sciences and is based in New Orleans, Louisiana. Its latest recorded funding round was a Series A Extension round in June 2022.
Fibronostics is a healthcare technology company that provides non-invasive, AI-driven diagnostic solutions for chronic, metabolic, and liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fibronostics Comparables
Compare Fibronostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPredictive | 85% | |
| MetaDeq | 82% | |
| Oncoustics | 78% |
For institutional investors. Book with your work email.
Fibronostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 15, 2022 | ||||
| Series A | Aug 24, 2020 | ||||
| Seed | May 31, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fibronostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tikehau Capital | Series A |
| AT Capital Group | Series A |
| SPRIM Global Investments | Seed, Series A |
| Elev8.vc | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors increased 34% MoM.
- Jun 1, 2025
Monthly visitors grew 33% MoM.
For institutional investors. Book with your work email.
Fibronostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fibronostics's valuation, stock price, and market status.
Is Fibronostics a public or private company?
Fibronostics is a private company.
What is the current stock price of Fibronostics?
Fibronostics is a private company, so its shares have no public market price. Caplight tracks Fibronostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fibronostics worth (valuation)?
Valuation information for Fibronostics is not publicly available.
Can I buy Fibronostics stock?
Fibronostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fibronostics's last funding round?
Fibronostics's most recent funding round was Series A Extension on June 15, 2022.
Who are the main investors in Fibronostics?
Key investors in Fibronostics include AT Capital Group, Elev8.vc.
Will Fibronostics IPO soon?
No public IPO plans have been announced for Fibronostics.
How can I track Fibronostics secondary market activity?
Caplight tracks bids, offers, and trades in Fibronostics's shares on secondary markets.